Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Raghava N. Sriramaneni"'
Autor:
Kathleen A. O’Leary, Amber M. Bates, Won Jong Jin, Brian M. Burkel, Raghava N. Sriramaneni, Sarah E. Emma, Erin J. Nystuen, Elizabeth G. Sumiec, Suzanne M. Ponik, Zachary S. Morris, Linda A. Schuler
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background Most patients with estrogen receptor positive (ER+) breast cancer do not respond to immune checkpoint inhibition (ICI); the tumor microenvironment (TME) of these cancers is generally immunosuppressive and contains few tumor-infilt
Externí odkaz:
https://doaj.org/article/ed62145c75cf435aa09efab35a43623c
Autor:
Ying Zhang, Raghava N. Sriramaneni, Paul A. Clark, Justin C. Jagodinsky, Mingzhou Ye, Wonjong Jin, Yuyuan Wang, Amber Bates, Caroline P. Kerr, Trang Le, Raad Allawi, Xiuxiu Wang, Ruosen Xie, Thomas C. Havighurst, Ishan Chakravarty, Alexander L. Rakhmilevich, Kathleen A. O’Leary, Linda A. Schuler, Paul M. Sondel, Kyungmann Kim, Shaoqin Gong, Zachary S. Morris
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-17 (2022)
Radiotherapy can activate an in situ vaccine response and promote response to immune checkpoint inhibitors. Here the authors design a multifunctional nanoparticle to enhance tumor antigen presentation and modulate the tumor immune microenvironment fo
Externí odkaz:
https://doaj.org/article/5182a8b990d848bdaa69308ac2077051
Autor:
Amber M. Bates, Ryan J. Brown, Alexander A. Pieper, Luke M. Zangl, Ian Arthur, Peter M. Carlson, Trang Le, Gustavo A. Sosa, Paul A. Clark, Raghava N. Sriramaneni, KyungMann Kim, Ravi B. Patel, Zachary S. Morris
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Surgical resection or hypo-fractionated radiation therapy (RT) in early-stage non-small cell lung cancer (NSCLC) achieves local tumor control, but metastatic relapse remains a challenge. We hypothesized that immunotherapy with anti-CTLA-4 and bempega
Externí odkaz:
https://doaj.org/article/a1b857248b16405ead2ae0e0249723e4
Autor:
Won Jong Jin, Amy K. Erbe, Ciara N. Schwarz, Abigail A. Jaquish, Bryce R. Anderson, Raghava N. Sriramaneni, Justin C. Jagodinsky, Amber M. Bates, Paul A. Clark, Trang Le, Keng-Hsueh Lan, Yi Chen, KyungMann Kim, Zachary S. Morris
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In head and neck squamous cell carcinoma (HNSCC) tumors that over-expresses huEGFR, the anti-EGFR antibody, cetuximab, antagonizes tumor cell viability and sensitizes to radiation therapy. However, the immunologic interactions between cetuximab and r
Externí odkaz:
https://doaj.org/article/cb1c402282874fdc932a12949b4cd965
Autor:
Claire C. Baniel, Clinton M. Heinze, Anna Hoefges, Elizabeth G. Sumiec, Jaquelyn A. Hank, Peter M. Carlson, Won Jong Jin, Ravi B. Patel, Raghava N. Sriramaneni, Stephen D. Gillies, Amy K. Erbe, Ciara N. Schwarz, Alexander A. Pieper, Alexander L. Rakhmilevich, Paul M. Sondel, Zachary S. Morris
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
In a syngeneic murine melanoma (MEL) model, we recently reported an in situ vaccination response to combined radiation (RT) and intra-tumoral (IT) injection of anti-GD2 hu14. 18-IL2 immunocytokine (IC). This combined treatment resulted in 71% complet
Externí odkaz:
https://doaj.org/article/69d352c38672413f9676b26e4741f6de
Autor:
Ying Zhang, Md Mahfuzur Rahman, Paul A. Clark, Raghava N. Sriramaneni, Thomas Havighurst, Caroline P. Kerr, Min Zhu, Jamie Jones, Xiuxiu Wang, KyungMann Kim, Shaoqin Gong, Zachary S. Morris
Publikováno v:
ACS Nano.
Autor:
Paul M. Sondel, Paul M. Harari, Alexander L. Rakhmilevich, Jacquelyn A. Hank, Amy K. Erbe, Alan J. Korman, Stephen D. Gillies, Hans Loibner, Lakeesha L. Carmichael, Raghava N. Sriramaneni, Abigail A. Jaquish, Sara M. Busche, Jasdeep S. Kler, Clinton M. Heinze, Peter M. Carlson, Lauryn R. Werner, Emily I. Guy, Zachary S. Morris
Concomitant immune tolerance prevents an immunotherapeutic response at the distant tumor site, is observed with an 8 Gy x 3 fraction RT regimen, and requires a well-established macroscopic secondary tumor.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92254349c1fed9f2a810f37376c5a2d7
https://doi.org/10.1158/2326-6066.22539017.v1
https://doi.org/10.1158/2326-6066.22539017.v1
Autor:
Paul M. Sondel, Paul M. Harari, Alexander L. Rakhmilevich, Jacquelyn A. Hank, Amy K. Erbe, Alan J. Korman, Stephen D. Gillies, Hans Loibner, Lakeesha L. Carmichael, Raghava N. Sriramaneni, Abigail A. Jaquish, Sara M. Busche, Jasdeep S. Kler, Clinton M. Heinze, Peter M. Carlson, Lauryn R. Werner, Emily I. Guy, Zachary S. Morris
In situ vaccination is an emerging cancer treatment strategy that uses local therapies to stimulate a systemic antitumor immune response. We previously reported an in situ vaccination effect when combining radiation (RT) with intratumor (IT) injectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e318cbf624cef92a30ae9c67df48f38
https://doi.org/10.1158/2326-6066.c.6548969
https://doi.org/10.1158/2326-6066.c.6548969
Autor:
Paul M. Sondel, Paul M. Harari, Alexander L. Rakhmilevich, Jacquelyn A. Hank, Amy K. Erbe, Alan J. Korman, Stephen D. Gillies, Hans Loibner, Lakeesha L. Carmichael, Raghava N. Sriramaneni, Abigail A. Jaquish, Sara M. Busche, Jasdeep S. Kler, Clinton M. Heinze, Peter M. Carlson, Lauryn R. Werner, Emily I. Guy, Zachary S. Morris
Supplemental Figure Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94e0aef92280465dad14cf60df132bde
https://doi.org/10.1158/2326-6066.22539008.v1
https://doi.org/10.1158/2326-6066.22539008.v1
Autor:
Justin C Jagodinsky, Amber M Bates, Paul A Clark, Raghava N Sriramaneni, Thomas C Havighurst, Ishan Chakravarty, Erin J Nystuen, KyungMann Kim, Paul M Sondel, Won Jong Jin, Zachary S Morris
Publikováno v:
Journal for immunotherapy of cancer. 10(10)
BackgroundRadiation therapy (RT) has been demonstrated to generate an in situ vaccination (ISV) effect in murine models and in patients with cancer; however, this has not routinely translated into enhanced clinical response to immune checkpoint inhib